Alpha Wave Global (formerly Falcon Edge Capital) is a global alternative asset manager and venture investment firm based in New York, founded in 2012. It invests across private equity, private credit, public markets, and venture capital, focusing on growth-stage technology companies in sectors such as AI, fintech, and life sciences.
Deal activity increased 50% year-over-year (6 deals in the last 12 months). Average disclosed round size is $130.5M (across 140 rounds with reported amounts).
Portfolio
110
Fund Size
$10B
Top Stage
Series A
Last 12 Mo
6
Team
Ravi Thakran
Partner, Former Group Chairman, LVMH Moët Hennessy Louis Vuitton Group Asia
Francis Suarez
President
Matthew Corey
Co-Chief Operating Officer and Chief Financial Officer
George Yang
Partner and Head of China
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| CCour Pharma | Series B | $50M | Jun 2026 |
 Ramp Network | Series F | $750M | Jun 2026 |
 Ramp | Series F | $750M | Jun 2026 |
 Nxtra by Airtel | Growth | — | Mar 2026 |
 Cerebras | Series H | — | Feb 2026 |
 Chaayos | Series C | $45M | Jan 2026 |
| CCour Pharma | Series B | $50M | Jan 2026 |
 Anthropic | Series G | — | Jan 2026 |
| AAnthropic, PBC | Series G | — | Jan 2026 |
 Metsera | Series B | $215M | Jan 2026 |
| Ramp | Growth | — | Nov 2025 |
 Tavily | Series A | $20M | Aug 2025 |
 AtaiBeckley | Series C | $125M | Feb 2025 |
 Lucidity | Series A | $21M | Feb 2025 |
| AtaiBeckley | Series C | — | Jan 2025 |
 Polytrade | Seed | $3.8M | Jan 2025 |
| Metsera | Series B | — | Nov 2024 |
| Ramp | Series D | $150M | Apr 2024 |
| AAttralus | Series B | $201M | Feb 2024 |
| CCour Pharma | Series A | $105M | Jan 2024 |
 Human Immunology Biosciences (HI-Bio) | Series B | $95M | Jan 2024 |
| HHI-Bio | Series B | $95M | Jan 2024 |
 Piersight | Seed | $7M | Jan 2024 |
 Mswipe | Unknown | $20M | Jan 2024 |
 Even | Unknown | $30M | Jan 2024 |
Top Co-Investors
Last updated: 20 October 2026